Skip to content

Arcus Biosciences

US · RCUS #2467 by market cap Listed 2018
15.62 -0.16 -1.01%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:39

About Arcus Biosciences

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Founded
2015
CEO
Dr. Terry Rosen, PhD
Employees
601
Headquarters
Hayward, California, United States of America
Fiscal year end
12-31
Website
arcusbio.com

Company profile

Exchange
US
Symbol
RCUS
Market-cap rank
#2467
Listing date
2018-03-15
Market cap
2.25B
Float cap
1.67B
Shares out
143.99M
Float shares
107.19M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:39:06 · For reference only, not investment advice and not tailored to your situation.

Arcus Biosciences discussion 0 comments

Add a comment